U.S. markets closed

Kintara Therapeutics, Inc. (KTRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5400+0.0100 (+0.65%)
At close: 4:00PM EDT
Sign in to post a message.
  • L
    Liberty
    In a note to clients on July 6, analysts at Aegis Capital Corp maintained their ‘Buy’ rating and $7 price target on shares of Kintara Therapeutics, which they said is predicated on a discounted cash flow valuation model that contemplates future revenues from the company’s therapeutics VAL-083 for glioblastoma (GBM) and REM-001 for cutaneous metastatic breast cancer (CMBC).

    “We think Kintara's VAL-083 represents an opportunity to benefit patients suffering from GBM, a highly lethal form of brain cancer. Given its unique mechanism of action, VAL-083 may be positioned to offer greater benefits to patients in the MGMT-unmethylated subset, which has historically responded poorly to standard of care,” the analysts wrote.

    “With that said, we think VAL-083 has multiple opportunities to demonstrate efficacy in conjunction with GCAR's GBM AGILE trial, including in newly diagnosed MGMT-methylated and unmethylated, and in patients with recurrent disease.”

    The Aegis Capital analysts called Kintara’s recent Phase 2 results for VAL-083 in patients with recurrent GBM ”positive,” noting the median overall survival (mOS) in the 30 milligram (mg) dosing regimen (48 efficacy evaluable patients) was 8.0 months, compared with 7.2 months for the chemotherapy drug lomustine, which they said is considered a beneficial outcome given the severity of the disease especially if the safety/tolerability profile of the drug is amenable.
    Bullish
  • L
    Liberty
    Kintara Therapeutics is developing innovative cancer therapies for rare, unmet medical needs.
    https://www.proactiveinvestors.co.uk/companies/news/937995/kintara-therapeutics-is-developing-innovative-cancer-therapies-for-rare-unmet-medical-needs-937995.html

    In a note to clients on July 6, analysts at Aegis Capital Corp maintained their ‘Buy’ rating and $7 price target on shares of Kintara Therapeutics, which they said is predicated on a discounted cash flow valuation model that contemplates future revenues from the company’s therapeutics VAL-083 for glioblastoma (GBM) and REM-001 for cutaneous metastatic breast cancer (CMBC).
    Bullish
  • L
    Liberty
    This is how stocks react once they are over bought. I traded out on the 24th to collect a sizable gain of over $23K. I could have waited till the 24th and had even more gains, but I knew from the chart showed that the stock would sell off soon. Almost all biotech stocks went down after their pops on Thursday.

    Nothing wrong with KTRA the company or their progress for VAL-083, I will be looking to buy back in when the chart shows a good entry point.
  • S
    Steve
    The VAL-083 Phase 2 data was due 2Q. Does anyone have any info?
  • G
    G550
    8 months survival
    Bullish
  • D
    Diana
    ⭐ Top Trades Ideas For July 2021 >>

    https://chart-analysis.tools/top-trade-idea
    Bullish
  • S
    Small
    we are about to spike
    Bullish
  • t
    tdog
    if you watch the ceo's video you will see they only released the results for the toughest group of the 3, being recurrent patients. He points out that the safety is much better than soc. interesting results should be coming out for the other two groups. https://youtu.be/fuGC2wlDJrE
  • S
    Small
    time to go up high
    Bullish
  • S
    Saad
    I like KTRA chart it is definitely bullish in monthly, weekly and daily charts. The beauty about the chart, it is more bullish in this order, daily, weekly, and monthly which makes it perfect. There are a few resistance I am not worried about it. It is going to be a good week. GLTA
    Bullish
  • S
    Saad
    It is a good time for more, I loaded more at $1.77. the lowest it can go was $1.72
    Bullish
  • M
    Martin
    Gooood morning! Short volume yesterday was above 50%!!! This is pure manipulation and this really is not a free market when SEC let’s big money HF continue this trend!!!
    Let’s hope they stop their senseless shorting today….

    https://www.shortvolume.com/?t=KTRA
    Bullish
  • H
    H
    What’s wrong with this stock?!
  • G
    G
    keep hold and buy on dips
    Bullish
  • S
    Saad
    Yesterday wasn't good for KTRA. let's hope it does not go below $2.05 otherwise it is reversing the trend down. If today close above $2.09 we would be Ok and will continue the trend upward
  • m
    miki
    Go to 💯 Dollar Baby 🚀🚀🚀🚀🚀🤪🤪🤪
  • G
    G
    keep holding long and strong. Shorts will be squeezed out
    Bullish
  • M
    Maz
    Not looking forward to the stock dropping as shorts will start taking profits
  • M
    Martin
    How is this possible? They deliver what I would call amazing news regarding their phase 2. And this go up over 20% before it turns red for the day?
    Either almost 50% of the shareholders take profit and at the same time slot of new short sellers. Or this is being manipulated by some big money HF…
    God sake i am tired of the Hf stealing our money….
  • D
    Darrell
    When do you expect they’ll announce an offering ? Looks like they only have about $16 mil in cash...
    Neutral